2020
Overview
Antiplatelet therapy is an important area of research in the field of hematology and oncology. As the name suggests, it is a therapy that is used to prevent blood platelets from clumping together and forming clots, which can lead to serious health complications such as heart attack and stroke. Antiplatelet drugs are commonly used for the prevention and treatment of diseases related to blood clotting, such as deep vein thrombosis and pulmonary embolism. One of the most commonly used antiplatelet drugs is aspirin, which is a non-steroidal anti-inflammatory drug that has the ability to inhibit platelet aggregation. In addition to aspirin, there are several other types of antiplatelet drugs that are used in the treatment of cardiovascular diseases. These include clopidogrel, ticagrelor, and prasugrel, all of which work by blocking the action of a chemical compound called adenosine diphosphate (ADP), which is responsible for platelet activation. Anticoagulants are another class of drugs that are often used in conjunction with antiplatelet therapy to help prevent blood clots from forming. These drugs work by inhibiting the clotting factors in the blood, thus reducing the risk of clot formation. In summary, antiplatelet therapy is an important area of research in the field of hematology and oncology. It involves the use of drugs that prevent the formation of blood clots, thus reducing the risk of serious health complications such as heart attack and stroke. As new drugs and treatments are developed, the efficacy and safety of antiplatelet therapy will continue to improve.
Research published in this journal
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2015
How this research is being cited
The 2 articles above have been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2015 · Journal of Neurological Research And Therapy
A sample of recent works citing this journal's research on Antiplatelet Therapy, linking to each citing work.